Download
Pharmaceutical_pricing_policies_European_countries_2015.pdf 618,19KB
WeightNameValue
1000 Titel
  • Pharmaceutical pricing policies in European countries
1000 Titelzusatz weitere
  • final report
1000 Verantwortlich
  • authors: Sabine Vogler, Katharina Habimana ; assistent: Brigitte Marsteuer ; commissioned by Change to Win ; Gesundheit Österreich Forschungs- und Planungs GmbH
1000 Beteiligung
Gesundheit Österreich GmbH (Herausgeber/in) |
Change to Win (Im Auftrag von) |
1000 Autor/in
  1. Vogler, Sabine |
  2. Habimana, Katharina |
  3. Marsteurer, Brigitte |
  4. Gesundheit Österreich GmbH |
  5. Change to Win |
1000 Katalog Id
  • HT020135223
1000 Erscheinungsort Wien
1000 Verlag Gesundheit Österreich Forschungs- und Planungs GmbH
1000 Erscheinungsjahr 2014
1000 Art der Datei
1000 Publikationstyp
  1. Monografie |
  2. Report |
1000 FRL-Sammlung
1000 Sprache der Publikation
1000 Abstract/Summary
  • European policy makers have been struggling to fulfil the partially conflicting policy goals of (1) granting equitable and timely access to medicines to their citizens, (2) rewarding innovation to pharmaceutical industry and (3) containing costs in order to ensure long-term financial sustainability of the health care system. From 2007/2008 on, Europe was affected by the global financial crisis that hit the countries in the region to different extents. Several countries had to take strict austerity measures, also in the pharmaceutical. Such measures are intended to address market participants such as pharmaceutical industry, wholesalers and pharmacies. Cost-containment is likely to also target patients and consumers by impacting accessibility and affordability of medicines. Change to Win, a US-based non-profit labor organization, addressed Gesundheit Österreich Forschungs- und Planungsgesellschaft GmbH, a legal subsidiary of Gesundheit Österreich GmbH (GÖG/Austrian Health Institute) for non-profit clients, to submit a report about pharmaceutical pricing in European countries in order to investigate measures taken during the global financial crisis and to provide an outlook on planned and future policy measures. The report is intended to be used by CtW Investment Group, which works with pension funds sponsored by unions affiliated with the Change to Win labor federation. In the results section, we start by providing an outlook on the current pattern and expected trends related to pharmaceutical policies as well as a forecast on pharmaceutical expenditure in the European countries over the next years . This is followed by information about most frequently applied policies related to pharmaceutical wholesale, pharmaceutical pricing in general and the commonly applied pricing policy of external price referencing.
1000 Sacherschließung
ddc 610 Medizin und Gesundheit
1000 DOI 10.4126/FRL01-006415227 |
1000 Dateien
  1. Pharmaceutical pricing policies in European countries
1000 Umfang
  • 1 Online-Ressource (III, 20 Seiten)
1000 Formschlagwörter
1000 Objektart monograph
1000 Beschrieben durch
1000 @id frl:6415227.rdf
1000 Erstellt am 2019-07-17T08:02:38.877+0200
1000 Erstellt von 25
1000 beschreibt frl:6415227
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet Fri Jul 19 05:04:10 CEST 2019
1000 Objekt bearb. Wed Jul 17 08:04:01 CEST 2019
1000 ähnlich zu
1000 Vgl. frl:6415227
1000 Oai Id
  1. oai:frl.publisso.de:frl:6415227 |
1000 Identisch zu
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Beschrieben durch
1000 Download
1000 Bestand
1000 Lobid

View source